Mucosal Atrophy
Mucosal Atrophy - Related Videos
01:21
Detection of Brain Atrophy by Hematoxylin and Eosin Staining
0 Views •
2025
To detect brain atrophy, begin with slides carrying the deparaffinized brain sections from neurodegenerative mouse models at various ages.
10:50
Tibial Nerve Transection - A Standardized Model for Denervation-induced Skeletal Muscle Atrophy in Mice
0 Views •
Cited by 38 •
2013
The tibial nerve transection model is a well-tolerated, validated, and reproducible model of skeletal muscle atrophy. The model surgical protocol is described and demonstrated in C57Black6 mice.
02:55
Quantification of Immune Mediator Levels in Human Mucosal Lining Fluid
0 Views •
2025
This video demonstrates the quantification of immune mediator levels in neonatal human nasal mucosal lining fluid extract. An electrochemiluminescence-based multiplex assay system measures these mediators by evaluating the intensity of emitted light when they are excited.
08:25
Heterotopic Mucosal Engrafting Procedure for Direct Drug Delivery to the Brain in Mice
0 Views •
Cited by 5 •
2014
A mouse model of human endoscopic skull base reconstruction has been developed that creates a semipermeable interface between the brain and nose using nasal mucosal grafts. This method allows researchers to study delivery to the central nervous system of high molecular weight therapeutics which are otherwise excluded by the blood-brain barrier when administered systemically.
01:25
Mucosal Barrier of the Stomach
0 Views •
2024
The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl. Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
FAQs
These three processes help maintain tissue thickness and function in different ways. Epithelial renewal replaces cells lost through normal wear, glandular secretion supports moisture and lubrication, and blood supply provides support for ongoing tissue maintenance. When one or more cannot meet local demands, the mucosa may lose structural resilience and become more vulnerable to irritation, injury, or impaired barrier performance.
Aging, hormonal changes, chronic inflammation, injury, and reduced stimulation can each alter the conditions required for mucosal maintenance. Their effects may differ across the gastrointestinal, respiratory, urinary, and reproductive tracts. Identifying the contributing factor is important because assessment and treatment should address the underlying condition rather than focus only on symptoms such as dryness, pain, or bleeding.
Functional decline can weaken the membrane’s protective and lubricating roles. Reduced lubrication may increase friction and irritation, while structural thinning can make tissue more prone to injury and bleeding. If barrier protection becomes less effective, exposure to damaging conditions or infectious agents may have greater consequences. These linked effects help explain why symptoms can vary in severity and type.
The clinical setting depends on which mucous membrane is affected and which functions are most important at that site. Changes may be expressed through impaired lubrication, reduced barrier protection, irritation, pain, bleeding, or greater susceptibility to injury and infection. Considering the involved organ system helps clinicians interpret symptoms and select an examination and tissue assessment appropriate to the affected tract.
Evaluation should connect symptoms with the affected mucosal site and possible contributing conditions. Clinicians may consider dryness, irritation, bleeding, pain, and signs of increased susceptibility to injury or infection, while examining tissue structure and function. The assessment should also explore aging, hormonal changes, inflammation, injury, reduced stimulation, or other context that could explain impaired maintenance.
Management is guided by the cause, the affected tract, and the resulting functional problems. Clinical care may combine symptom management with measures intended to restore local conditions or address contributing disease. This cause-oriented approach can help improve dryness, irritation, pain, or bleeding while also supporting barrier protection and reducing the consequences of continued tissue vulnerability.